CClinicalTrials.gg
CompletedNCT01700062Updated Oct 4, 2012

Medium Calorie Parenteral Nutrition on Patients With Gastrointestinal Cancer Undergoing Surgery

A Phase 4 interventional study of Total Parenteral Nutrition (TPN) in Colorectal Neoplasms, sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Completed at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-10-04.

Sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital · Phase 4 and Interventional

Phase
Phase 4
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

aimed at investigating the efficacy, safety, and clinical outcome of Medium-Calorie or standard-calorie total parenteral nutrition (TPN) for patients with gastrointestinal cancer undergoing surgery

Read the detailed description

biochemistry data Various inflammation-related cytokines clinical outcome hospital stay

02

Conditions studied

  • Colorectal Neoplasms

Keywords

  • medium-calorie
  • standard calorie
  • parenteral nutrition
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's enrollment of 40 is below the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital is the lead sponsor of 281 studies on the registry; 57 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients considered for major surgery for colorectal cancer Expected requirement for post operative PN or TPN of at least for 7 days Age >18 Hemodynamically stable Written Informed Consent

Exclusion criteria

Exclusion Criteria:

  • Hemodynamic failure of any organ Renal insufficiency Patients with severe liver dysfunction Albumin \< 3g/dL DM with poor blood sugar control
05

Study design

Phase
Phase 4
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Medium calorie

    Dietary Supplement: Total Parenteral Nutrition (TPN)

  • Experimental
    standard calorie

    Dietary Supplement: Total Parenteral Nutrition (TPN)

Interventions

  • Dietary supplementTotal Parenteral Nutrition (TPN)

    Medium calorie ,Nonprotein calories 20 Kcal/Kg/day,Protein 1g/Kg,Fat emulsion 0.5 g/kg/day D1-D6 post OP standard calorie, Nonprotein calories 30 Kcal/Kg/day,Protein 1.5 g/Kg,Fat emulsion 50g/day D1-D6 post OP

06

What researchers measure

Primary outcomes

  1. biochemistry data; Various inflammation-related cytokines ;

    Time frame: 7 days

Secondary outcomes

  1. clinical outcome(hospital stay..)

    Time frame: 2 months

07

Study locations

1 site
  • Kaohsiung Medical University Hospital
    Kaohsiung, 80756, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 4, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01700062
Lead sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Responsible party
JUI-FEN CHUANG (Department of pharmacy, leader, Kaohsiung Medical University Chung-Ho Memorial Hospital) — Principal investigator
First posted
Oct 4, 2012
Start date
Apr 2007
Primary completion
Nov 2008
Completion
Dec 2008
Last update
Oct 4, 2012

Study contacts

JF CHUANG, M.S.
principal investigator · Department of pharmacy, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
JY WANG, M.D.
study chair · Departments of Surgery Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
YB HUANG, Ph.D.
study director · Departments of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion